[HTML][HTML] Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options

FZ Francies, R Hull, R Khanyile… - American journal of …, 2020 - ncbi.nlm.nih.gov
Breast cancer is a common malignancy among women worldwide. Regardless of the
economic status of a country, breast cancer poses a burden in prevention, diagnosis and …

[HTML][HTML] EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

D Pradella, C Naro, C Sette, C Ghigna - Molecular cancer, 2017 - Springer
Epithelial-to-mesenchymal transition (EMT) is associated with metastasis formation as well
as with generation and maintenance of cancer stem cells. In this way, EMT contributes to …

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells

S Calabretta, P Bielli, I Passacantilli, E Pilozzi… - Oncogene, 2016 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and incurable disease. Poor
prognosis is due to multiple reasons, including acquisition of resistance to gemcitabine, the …

[HTML][HTML] Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer

AR Farina, L Cappabianca, M Sebastiano… - Journal of Experimental …, 2020 - Springer
Hypoxia-induced alternative splicing is a potent driving force in tumour pathogenesis and
progression. In this review, we update currents concepts of hypoxia-induced alternative …

Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer

E Sebestyén, M Zawisza, E Eyras - Nucleic acids research, 2015 - academic.oup.com
The determination of the alternative splicing isoforms expressed in cancer is fundamental for
the development of tumor-specific molecular targets for prognosis and therapy, but it is …

[HTML][HTML] Alternative splicing: the pledge, the turn, and the prestige: the key role of alternative splicing in human biological systems

LM Gallego-Paez, MC Bordone, AC Leote… - Human genetics, 2017 - Springer
Alternative pre-mRNA splicing is a tightly controlled process conducted by the spliceosome,
with the assistance of several regulators, resulting in the expression of different transcript …

[HTML][HTML] Circulating RNAs as new biomarkers for detecting pancreatic cancer

T Kishikawa, M Otsuka, M Ohno… - World journal of …, 2015 - ncbi.nlm.nih.gov
Pancreatic cancer remains difficult to treat and has a high mortality rate. It is difficult to
diagnose early, mainly due to the lack of screening imaging modalities and specific …

Evolving lessons on the complex role of AMPK in normal physiology and cancer

B Dasgupta, RR Chhipa - Trends in pharmacological sciences, 2016 - cell.com
AMP kinase (AMPK) is an evolutionarily conserved enzyme required for adaptive responses
to various physiological and pathological conditions. AMPK executes numerous cellular …

Tamoxifen mechanically reprograms the tumor microenvironment via HIF‐1A and reduces cancer cell survival

E Cortes, D Lachowski, B Robinson, M Sarper… - EMBO …, 2019 - embopress.org
The tumor microenvironment is fundamental to cancer progression, and the influence of its
mechanical properties is increasingly being appreciated. Tamoxifen has been used for …

The alternative splicing side of cancer

G Biamonti, M Catillo, D Pignataro… - Seminars in cell & …, 2014 - Elsevier
Alternative splicing emerges as a potent and pervasive mechanism of gene expression
regulation that expands the coding capacity of the genome and forms an intermediate layer …